Inhibition of tumor growth and angiogenesis by soluble EphB4. - Wikidata - awgldk - TriplyDB

Inhibition of tumor growth and angiogenesis by soluble EphB4.

Inhibition of tumor growth and angiogenesis by soluble EphB4.

http://www.wikidata.org/entity/Q34770033

about

Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity Guidance molecules in lung cancer Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma.A review of the past, present, and future directions of neoplasia Coming of Age in the Life of The Role of PTEN in Tumor Angiogenesis Neoplasia: Where We Have Been and Where We Are Going PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth.Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression Eph receptors and ephrins in cancer: bidirectional signalling and beyond.Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma.EPHB4 gene polymorphisms and risk of intracranial hemorrhage in patients with brain arteriovenous malformations.Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols.Lentivirus vector-mediated knockdown of erythropoietin-producing hepatocellular carcinoma receptors B4 inhibits laser-induced choroidal neovascularization.Inhibition of choroidal neovascularization by anti-EphB4 monoclonal antibody.EphB4 expression in pterygium is associated with microvessel density Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth Eph receptors and ephrins as targets for cancer therapy.A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.Developments towards effective treatments for Nipah and Hendra virus infection.Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases.Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?Eph receptors in breast cancer: roles in tumor promotion and tumor suppression.Targeted strategies for henipavirus therapeutics Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.EphB4 tyrosine kinase stimulation inhibits growth of MDA-MB-231 breast cancer cells in a dose and time dependent manner.Ephrin expression and function in cancer.Axon guidance molecules in vascular patterning.The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.Therapeutic targeting of EPH receptors and their ligands.Inhibiting Eph kinase activity may not be "Eph"ective for cancer treatment.The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors.The marine-derived pachycladin diterpenoids as novel inhibitors of wild-type and mutant EGFR.EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer target.

P2860

Q21328694-EF926C80-174C-4913-9D6F-E7FAD36D7BEE Q24298026-C8C14345-0FB5-4E5C-AE47-F579828BECC2 Q24598659-5DA2FD18-4310-4BD4-9A27-689C331068C4 Q24815816-3BA47BB2-F3A9-4183-97EA-634F78DA978D Q28389391-FE6618F3-96E1-414C-A6F0-79046C8A6E62 Q28389985-1D49A0E4-A7DA-4ADE-BE6C-186E8260B5AB Q28391620-30F5C86C-E500-4DE7-923A-986D24F4587E Q28395095-CA1881DB-7927-4419-A4EA-36D2A2DA926A Q28741459-2DBE42BB-FCEF-4788-91F3-B5792475BE7B Q33677805-1A527BD1-54AC-4749-80E9-0D1631498051 Q33745300-CB9B1150-776A-4C7E-B5CB-8BE82B61DF87 Q33858304-63477EA7-2E4F-48E3-A99A-526DB74855D2 Q33965278-2B41BB18-BD82-423C-A18C-A5628169027D Q34021365-9F44329B-89EA-42EA-B98E-7C9FAA0CF466 Q34104147-D0B7E1F5-58D8-49F2-96B3-D02A8F676C1B Q34129223-F4EC5418-34DA-429A-88C7-30AFF8368619 Q34323180-A84A14C8-DD56-402D-B6AA-5CB2FCF7E8EA Q34433623-6B0156C4-8C80-4493-9B67-C9396A099CAB Q34676084-55CCBB58-A18D-405D-9553-545E6149789F Q34769816-60D2B209-B981-404C-B50B-AD434857F7F5 Q35060278-833A96A9-8216-4D24-821D-1AF0A6764A32 Q35370195-683D1356-1B86-4399-A44F-D132594331F8 Q35385982-E7B4F153-CA37-44DF-85CA-26A636A31F21 Q35783568-66AF4A87-9054-4AC8-B390-F26317E028EB Q35849505-54F282EC-7D31-427E-AB28-E943FDB32602 Q36379335-2974F07F-7ECF-473E-9027-BDE76A9714BD Q36765650-83DF3EB5-5C7C-40E6-A4A0-5C78EC665CCF Q37024040-2D2E4E9F-969C-4878-919F-ECEE1EAEFFEB Q37131357-B2D3861F-DB90-4BD1-99F7-8CD517913F82 Q37175177-E495D875-9A0C-4E07-B38A-9CEDD8A5FD0E Q37185221-204EBCD7-6ADA-4995-8518-661DA7225D91 Q37448572-F1494EB4-BA66-4064-A5AE-4902664E647E Q37658786-68349372-5A24-4FBA-B83B-4BE01161FC37 Q37746510-7D403177-A446-4EDA-8B7C-7651271859F9 Q38006838-10BEB259-AC8A-4DA7-9ECB-E3C6488E2BBE Q38174793-22E4EACA-6E3B-4D55-BFAF-49636665D658 Q38270107-2FFB08E0-F30F-4B0D-BEEF-7EA0E49F4DC0 Q38622722-58FCEB2D-C132-4EFC-A05D-68CC8E9A671A Q38726762-5E552886-D6A5-4702-9FE0-CC6000AA28F4 Q39354035-640687D8-E08B-4765-B4D5-05450F11120B

P2860

Inhibition of tumor growth and angiogenesis by soluble EphB4.

http://www.wikidata.org/entity/Q34770033

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Inhibition of tumor growth and angiogenesis by soluble EphB4.

@ast

Inhibition of tumor growth and angiogenesis by soluble EphB4.

@en

Inhibition of tumor growth and angiogenesis by soluble EphB4.

@nl

type

label

Inhibition of tumor growth and angiogenesis by soluble EphB4.

@ast

Inhibition of tumor growth and angiogenesis by soluble EphB4.

@en

Inhibition of tumor growth and angiogenesis by soluble EphB4.

@nl

prefLabel

Inhibition of tumor growth and angiogenesis by soluble EphB4.

@ast

Inhibition of tumor growth and angiogenesis by soluble EphB4.

@en

Inhibition of tumor growth and angiogenesis by soluble EphB4.

@nl

P1433

Q34770033-53089B30-19D5-4CC2-9A69-94A3F4BDF01D

P1476

Q34770033-1F2964B0-E355-43C3-AAFD-47EE09E0A1A7

P2093

Q34770033-1BFCD0B0-575D-4E57-9D80-1C3B10F25C8A

Q34770033-4C15565D-A4E2-48B9-9385-BAE02C30A0EC

Q34770033-6EABAB0B-4675-430F-BB30-A03B4D4DA466

Q34770033-94A7AEA1-63F2-4800-9215-940A451BC1DF

Q34770033-D1B048D9-8C7F-4AFF-BC4D-E5A7552B6BAF

Q34770033-DACBCCA7-A40B-4B0D-A4DE-039094D1503B

Q34770033-F797EC6C-4B8C-472B-BF60-8D92CBA20133

P2860

Q34770033-015B861E-4E0A-4C80-B67E-C40B7A7EA896

Q34770033-0433BCCC-639B-4E31-AE1C-C5204195458E

Q34770033-048EAEB1-32A1-4B61-9E58-78ED6560571A

Q34770033-085CF62B-0C7C-4BC3-9EA6-34FA0D88CC1C

Q34770033-0CFEEB02-28B2-48C4-875F-38E962E70854

Q34770033-0D768D4B-D688-487B-BC97-612C91EF0235

Q34770033-18D1D698-62A0-4D8A-BD19-FC7531AD5861

Q34770033-1AC1B182-7C52-4275-9BA9-B231EBB82006

Q34770033-2737F3E9-37BF-46F2-9D78-DE452A84BFC6

Q34770033-3252951F-BF78-4E62-B4E1-EA34CD837718

P304

Q34770033-AFAF0B5A-8D57-4D2A-A4CC-3FAF4DA31EA6

P31

Q34770033-820C4987-B87D-4BA7-A0DA-F60BC8A05BEB

P356

Q34770033-F0B23585-8B84-4C75-B26A-DE1D8315B555

P433

Q34770033-BF1235B9-BFAC-4829-9EB2-166F795A4748

P478

Q34770033-B5692ECC-91C3-4780-AD42-C6BE83801FB8

P577

Q34770033-9D4B982A-DC8C-49B7-BDD5-E0AFF0D92870

P698

Q34770033-FBC91BEE-418A-4B70-835E-01F979789EFA

P932

Q34770033-205AA1B5-1C1B-494E-9BB1-A8B61376AD9C

P356

P1433

P1476

Inhibition of tumor growth and angiogenesis by soluble EphB4.

@en

P2093

Dieter Marmé

http://www.w3.org/2001/XMLSchema#string

Florence Schaffner

http://www.w3.org/2001/XMLSchema#string

Georg Martiny-Baron

http://www.w3.org/2001/XMLSchema#string

Hellmut G Augustin

http://www.w3.org/2001/XMLSchema#string

Norbert Esser

http://www.w3.org/2001/XMLSchema#string

Stefan Eggstein

http://www.w3.org/2001/XMLSchema#string

Thomas Korff

http://www.w3.org/2001/XMLSchema#string

P2860

Genes expressed in human tumor endothelium

Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells

Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4

VEGF-Trap: a VEGF blocker with potent antitumor effects.

Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis

Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma

Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer

Mechanisms and functions of Eph and ephrin signalling

Coexpression of ephrin-Bs and their receptors in colon carcinoma

Cytokine traps: multi-component, high-affinity blockers of cytokine action

P304

248-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.03457

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15153337

http://www.w3.org/2001/XMLSchema#string

P932

1502094

http://www.w3.org/2001/XMLSchema#string